Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas
- PMID: 3462743
- PMCID: PMC386652
- DOI: 10.1073/pnas.83.18.7059
Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas
Abstract
Mouse monoclonal antibody L6 (IgG2a subtype) recognizes a ganglioside antigen expressed at the surface of cells from human non-small-cell lung carcinomas, breast carcinomas, and colon carcinomas. We now show that this antibody can lyse L6 antigen-positive human tumor cells in the presence of Leu-11b-positive human lymphocytes (i.e., mediate antibody-dependent cellular cytotoxicity) or human serum (mediate complement-dependent cytotoxicity) and that it can inhibit the outgrowth of an L6 antigen-positive human tumor transplanted onto nude mice.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
